Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection

AIDS

Volumn 31, Issue 7, 2017, Pages 953-963

  Lifson, Alan R ^a   Grund, Birgit ^a   Gardner, Edward M ^b   Kaplan, Richard ^c   Denning, Eileen ^a   Engen, Nicole ^a   Carey, Catherine L ^d   Chen, Fabian ^e   Dao, Sounkalo ^f   Florence, Eric ^g   Sanz, Jesus ^h   Emery, Sean ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b DENVER PUBLIC HEALTH   (United States)

^c Institute of Infectious Disease and Molecular Medicine   (South Africa)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^f Centre de Recherche   (Mali)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^h HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Antiretroviral therapy; Clinical trial; HIV; Mental health; Quality of life

Indexed keywords

ABACAVIR; CD4 ANTIGEN; EFAVIRENZ; TENOFOVIR; ZIDOVUDINE; ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ASYMPTOMATIC INFECTION; CD4 LYMPHOCYTE COUNT; CLINICAL OUTCOME; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERCEPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF EVALUATION; SHORT FORM 12; VISUAL ANALOG SCALE; CLINICAL TRIAL; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TREATMENT OUTCOME;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; QUALITY OF LIFE; SECONDARY PREVENTION; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 85010903509     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001417     Document Type: Review

References (32)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at: www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf [Accessed 15 September 2016].
2. World Health Organization. Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV. Geneva: WHO; 2015, Available at: www.who.int/hiv/pub/ guidelines/earlyrelease-arv/en [Accessed 15 September 2016].
3. Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013;8:e81355.
4. Preamble to the constitution of theWorld Health Organization as adopted by the International Health Conference, New York, 19 June - 22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
5. Cella D. Quality of life: Concepts and definition. J Pain Symptom Management 1994;9:186-192.
6. Centers for Disease Control and Prevention. Measuring health days: population assessment of health-related quality of life. Atlanta: CDC; 2000, Available at: www.cdc.gov/hrqol/pdfs/ mhd.pdf [Accessed 15 September 2016].
7. Burgoyne RW, Tan DH. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. J Antimicrob Chemother 2008;61:469-473.
8. Burman WJ, Grund B, Roediger MP, Friedland G, Darbyshire J, Wu AW, SMART Study Group. The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life. J Acquir Immune Defic Syndr 2008;47:185-193.
9. Beard J, Feeley F, Rosen S. Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review. AIDS Care 2009;21:1343-1356.
10. Robberstad B, Olsen JA. The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study. Cost Eff Resour Alloc 2010;8:5.
11. de Boer-van der Kolk IM, Sprangers MAG, Prins JM, Smit C, de Wolf F, Nieuwkerk PT. Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort. Clin Infect Dis 2010;50:255-263.
12. Marcellin F, Bonono CR, Blanche J, Carrieri MP, Spire B, Koulla- Shiro S, EVAL Study Group. Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116). AIDS 2010;24 (Suppl 1):S17-S25.
13. Grijsen M, Koster G, van Vonderen M, van Kasteren M, Kootstra G, Steingrover R, et al. Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study. HIV Med 2012;13:630-635.
14. Oguntibeju OO. Quality of life of people living with HIV and AIDS and antiretroviral therapy. HIV AIDS (Auckl) 2012;4:117-124.
15. Drewes J, Gusy B, Rüden Uv. More than 20 years of research into the quality of life of people with HIV and AIDS: a descriptive review of study characteristics and methodological approaches of published empirical studies. J Int Assoc Provid AIDS Care 2013;12:18-22.
16. Gakhar H, Kamali A, Holodniy M. Health-related quality of life assessment after antiretroviral therapy: a review of the literature. Drugs 2013;73:651-672.
17. Bunupuradah T, Kosalaraksa P, Vibol U, Hansudewechakul R, Sophonphan J, Kanjanavanit S, et al. Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study. AIDS Patient Care STDs 2013;27:596-603.
18. Langebeek N, Sprenger HG, Gisolf EH, Reiss P, Sprangers MA, Legrand J, et al. A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. HIV Med 2014;15:286-290.
19. Lifson AR, Grandits GA, Gardner EM, Wolff MJ, Pulik P, Williams I, et al. Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med 2015;16 (Suppl 1):88-96.
20. Mekuria LA, Sprangers MA, Prins JM, Yalew AW, Nieuwkerk PT. Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa. AIDS Care 2015;27:934-945.
21. INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med 2015;373:795-807.
22. de Boer AG, van Lanschot JJ, Stalmeier PF, van Sandick JW, Hulscher JB, de Haes JC, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multiitem scales in measuring quality of life? Qual Life Res 2004;13:311-320.
23. Ware JE, Jr, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12 Health Survey (With a Supplement Documenting Version1). Lincoln, RI: QualityMetric Incorporated; 2002.
24. R Core Team. R: A Language and Environment For Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
25. Degroote S, Vogelaers D, Vandijck DM. What determines healthrelated quality of life among people living with HIV: an updated review of the literature. Arch Public Health 2014;72:40.
26. Mannheimer SB, Wold N, Gardner EM, Telzak EE, Huppler Hullsiek K, Chesney M, et al. Mild-to-moderate symptomsduring the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clin Infect Dis 2008;46:941-945.
27. Sordo del Castillo L, Ruiz-Perez I, Olry de Labry Lima A. Biological, psychosocial, therapeutic and quality of life inequalities between HIV-positive men and women: a review from a gender perspective. AIDS Rev 2010;12:113-120.
28. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171-1178.
29. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
30. Jenkinson C, Layte R, Jenkinson D, Lawrence K, Petersen S, Paice C, et al. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies? J Public Health Med 1997;19:179-186.
31. Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, et al. The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database. J Clin Epidemiol 2008;61:788-795.
32. Lee JW, Jones PS, Mineyama Y, Zhang XE. Cultural differences in responses to a Likert scale. Res Nurs Health 2002;25:295-306.